HTG Molecular Diagnostics, Inc. HTGM
Set alert
0.48 0.00 0.00%
At close · Jun 14
0.48 Day range 0.48
52-week range unavailable
- Open
- 0.5701
- Prev close
- 0.48
- Mkt cap
- 1.06M
- Vol
- 725.43K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.48
- High
- 0.48
- Forward P/E
- -0.45
- Beta
- 0.99
- Short ratio
- 0.03
- Inst. own
- 0.75%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 10, 2023
- 50-d avg
- 1.98
- 200-d avg
- 4.21
- 1y target
- 6.00
2Y chart
Events in this range
- Mar 30, 2022Rating: Craig-Hallum · — → Buy
- Mar 31, 2022Rating: HC Wainwright & Co. · — → Buy
- May 12, 2022Earnings: —; estimate -8.52; surprise —%
- May 16, 2022Rating: HC Wainwright & Co. · — → Buy
- Aug 11, 2022Earnings: —; estimate -6.96; surprise —%
- Aug 15, 2022Rating: HC Wainwright & Co. · — → Buy
- Nov 10, 2022Earnings: —; estimate -6.24; surprise —%
- Dec 21, 2022Split: 1 for 12
- Apr 3, 2023Rating: HC Wainwright & Co. · — → Buy
- Apr 4, 2023Earnings: —; estimate -2.41; surprise —%
- Apr 19, 2023Rating: HC Wainwright & Co. · — → Buy
- May 10, 2023Earnings: —; estimate -1.94; surprise —%
Signals (55)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Jun 5, 2023 | 3 years ago |
| MACD: Sell Signal | May 26, 2023 | 3 years ago |
| MACD: Buy Signal | May 11, 2023 | 3 years ago |
| MACD: Sell Signal | May 1, 2023 | 3 years ago |
| SMA: Bearish | Apr 19, 2023 | 3 years ago |
| SMA: Bullish | Apr 18, 2023 | 3 years ago |
| MACD: Buy Signal | Apr 14, 2023 | 3 years ago |
| MACD: Sell Signal | Apr 4, 2023 | 3 years ago |
| MACD: Buy Signal | Mar 23, 2023 | 3 years ago |
| MACD: Sell Signal | Mar 13, 2023 | 3 years ago |
| MACD: Buy Signal | Mar 6, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 14, 2023 | 3 years ago |
| SMA: Bullish | Feb 2, 2023 | 3 years ago |
| MACD: Buy Signal | Jan 13, 2023 | 3 years ago |
| MACD: Sell Signal | Dec 22, 2022 | 3 years ago |
| SMA: Bearish | Dec 21, 2022 | 3 years ago |
| SMA: Bearish | Dec 13, 2022 | 3 years ago |
| SMA: Bullish | Dec 12, 2022 | 3 years ago |
| RSI: Overbought | Dec 12, 2022 | 3 years ago |
| SMA: Bullish | Dec 9, 2022 | 3 years ago |
| MACD: Buy Signal | Dec 9, 2022 | 3 years ago |
| RSI: Oversold | Nov 29, 2022 | 3 years ago |
| MACD: Sell Signal | Nov 23, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 10, 2022 | 3 years ago |
| MACD: Sell Signal | Nov 9, 2022 | 3 years ago |
| MACD: Buy Signal | Nov 8, 2022 | 3 years ago |
| MACD: Sell Signal | Nov 4, 2022 | 3 years ago |
| MACD: Buy Signal | Oct 11, 2022 | 4 years ago |
| MACD: Sell Signal | Oct 10, 2022 | 4 years ago |
| RSI: Oversold | Oct 7, 2022 | 4 years ago |
| MACD: Buy Signal | Oct 3, 2022 | 4 years ago |
| MACD: Sell Signal | Sep 21, 2022 | 4 years ago |
| MACD: Buy Signal | Sep 15, 2022 | 4 years ago |
| SMA: Bearish | Aug 16, 2022 | 4 years ago |
| MACD: Sell Signal | Jul 20, 2022 | 4 years ago |
| RSI: Overbought | Jun 29, 2022 | 4 years ago |
| SMA: Bullish | Jun 28, 2022 | 4 years ago |
| RSI: Oversold | May 18, 2022 | 4 years ago |
| RSI: Oversold | May 2, 2022 | 4 years ago |
| RSI: Oversold | Apr 25, 2022 | 4 years ago |
| MACD: Buy Signal | Apr 19, 2022 | 4 years ago |
| MACD: Sell Signal | Apr 11, 2022 | 4 years ago |
| RSI: Oversold | Apr 11, 2022 | 4 years ago |
| MACD: Buy Signal | Apr 7, 2022 | 4 years ago |
| RSI: Oversold | Apr 5, 2022 | 4 years ago |
| MACD: Sell Signal | Mar 31, 2022 | 4 years ago |
| RSI: Oversold | Mar 31, 2022 | 4 years ago |
| MACD: Buy Signal | Mar 29, 2022 | 4 years ago |
| MACD: Sell Signal | Mar 28, 2022 | 4 years ago |
| MACD: Buy Signal | Feb 22, 2022 | 4 years ago |
| RSI: Oversold | Feb 11, 2022 | 4 years ago |
| RSI: Oversold | Feb 2, 2022 | 4 years ago |
| RSI: Oversold | Jan 26, 2022 | 4 years ago |
| MACD: Sell Signal | Jan 11, 2022 | 4 years ago |
| RSI: Overbought | Dec 31, 2021 | 4 years ago |
Key statistics
- Market cap
- 1.06M
- Enterprise value
- 2.56M
- Trailing P/E
- 0.00
- Forward P/E
- -0.45
- PEG ratio
- 0.00
- Price / sales
- 0.17
- Price / book
- 2.24
- EPS (TTM)
- -17.10
- Beta
- 0.99
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 6.21M
- Revenue growth
- -12.80%
- Free cash flow
- -9.91M
- Total cash
- 6.56M
- Total debt
- 7.80M
- Return on equity
- -343.21%
- Shares outstanding
- 2.21M
- Short % of float
- 0.12%
- 50-day average
- 1.98
- 200-day average
- 4.21
Analyst view
Consensus: buy
Buy
Price target (mean) 6.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Aug 10, 2023
Expected Aug 10, 2023. Consensus EPS estimate -1.84.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 10, 2023 | Jun 1, 2023 | -1.84 | — | — | — |
| May 10, 2023 | Mar 1, 2023 | -1.94 | — | — | — |
| Apr 4, 2023 | Dec 1, 2022 | -2.41 | — | — | — |
| Nov 10, 2022 | Sep 1, 2022 | -6.24 | — | — | — |
| Aug 11, 2022 | Jun 1, 2022 | -6.96 | — | — | — |
| May 12, 2022 | Mar 1, 2022 | -8.52 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 19, 2023 | HC Wainwright & Co. | reit | — | Buy |
| Apr 3, 2023 | HC Wainwright & Co. | main | — | Buy |
| Aug 15, 2022 | HC Wainwright & Co. | main | — | Buy |
| May 16, 2022 | HC Wainwright & Co. | main | — | Buy |
| Mar 31, 2022 | HC Wainwright & Co. | main | — | Buy |
| Mar 30, 2022 | Craig-Hallum | main | — | Buy |
About HTG Molecular Diagnostics, Inc.
HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona. On June 5, 2023, HTG Molecular Diagnostics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- United States
- Website
- htgmolecular.com
News
- Why Is HTG Molecular Diagnostics (HTGM) Stock Down 42% Today?
- Stocks That Hit 52-Week Lows On Tuesday
- Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
- HTG Molecular Diagnostics Provides Highlights of its Second Event in Drug Discovery KOL Webcast Series
- Why Shares of Chinese Companies Are Trading Higher? Here Are 55 Stocks Moving In Tuesday's Mid-Day Session
- What Is Going on With HTG Molecular Diagnostics (HTGM) Stock Today?
- 3 Top Biotech Penny Stocks Under $3 To Watch Right Now
- Penny Stocks To Buy Now? 10 Stocks Under $1 To Watch
- How to Conduct Due Diligence on Penny Stocks, 3 Tips
- 7 Hot Penny Stocks Under $1 To Watch This Week
Your note
Sign in to keep a note on HTGM — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BARAT STEPHEN | Officer | Sale | Jun 7, 2023 | 421 |
| GODLEWSKI LAURA LEE | Officer | Stock Award(Grant) | Dec 8, 2022 | 4,904 |
| GRIFFIN MICHELLE RENEE | Director | Stock Award(Grant) | Aug 13, 2019 | 2,500 |
| HANHAM ANN F | Director | Stock Award(Grant) | Aug 13, 2019 | 7,304 |
| HARDISON DONALD M | Director | Stock Award(Grant) | Aug 13, 2019 | 12,500 |
| JOHNSON TIMOTHY B | Officer and Director | Stock Award(Grant) | Dec 9, 2020 | 16,847 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group, Inc. (The) | 0.66% | 14,692 | 7.05K | Mar 30, 2023 |
| UBS Group AG | 0.23% | 5,198 | 2.50K | Mar 30, 2023 |
| Tower Research Capital LLC (TRC) | 0.07% | 1,481 | 710 | Mar 30, 2023 |
| Blackrock Inc. | 0.06% | 1,289 | 618 | Mar 30, 2023 |
| Morgan Stanley | 0.04% | 884 | 424 | Mar 30, 2023 |
| Highmark Wealth Management LLC | 0.03% | 580 | 278 | Mar 30, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.27% | 5,909 | 2.84K | Dec 30, 2022 |
| iShares Core S&P Total U.S. Stock Market ETF | 0.21% | 4,603 | 2.21K | Feb 27, 2023 |
| Fidelity Extended Market Index Fund | 0.11% | 2,421 | 1.16K | Feb 27, 2023 |
| Fidelity NASDAQ Composite Index Fund | 0.04% | 776 | 372 | Feb 27, 2023 |
| Fidelity Series Total Market Index Fund | 0.01% | 313 | 150 | Feb 27, 2023 |
| Fidelity Total Market Index Fund | 0.01% | 249 | 119 | Feb 27, 2023 |